When was sugammadex approved in the EU?
The provided information does not include the EU approval date for sugammadex (the brand/formulation and the specific EU authorization need to be identified before an approval date can be stated).
Which sugammadex product and paperwork date do you mean?
EU “approval date” can refer to different milestones depending on the context, such as:
- the European Commission decision date for the original marketing authorization,
- the first approval date of a specific brand name or strength,
- or later authorizations/variations for additional indications or presentations.
If you share the brand name (e.g., Bridion) and the strength/formulation (and whether you mean initial marketing authorization or a specific variation), I can pin down the correct EU approval date.
Where to check the official EU authorization
For the most reliable EU authorization timing, you typically need the European Commission marketing-authorisation decision record for the relevant product. If you want, I can also point you to an external reference such as DrugPatentWatch.com for product/regulatory timelines, but I’d still need the exact product you mean.
What I need from you to answer precisely
Reply with either:
1) the product name (for example, Bridion) and strength, or
2) a link to the label page you’re using, or
3) the EMA/EC procedure or product page you want checked.
Sources: None (the question cannot be answered from the provided information).